Atlas Trials

An Add-on Study to Evaluate the Efficacy and Safety of Xiyanping Injection in Pediatric Bronchitis Patients.

Clinical trial NCT02937857 · UNKNOWN

Trial details

NCT number
NCT02937857
Sponsor
Jiangxi Qingfeng Pharmaceutical Co. Ltd.
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Bronchitis
Start date
2016-08-01
Primary completion
2020-04-01
Enrollment
240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.